Cormedix Stock Today
| CRMD Stock | USD 5.45 0.17 3.22% |
Performance15 of 100
| Odds Of DistressLess than 32
|
CorMedix is trading at 5.45 as of the 23rd of April 2024, a 3.22 percent up since the beginning of the trading day. The stock's lowest day price was 5.26. CorMedix has about a 32 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Equity ratings for CorMedix are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of January 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of March 2010 | Category Healthcare | Classification Health Care |
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. The company has 54.98 M outstanding shares of which 8.25 M shares are currently shorted by private and institutional investors with about 15.92 trading days to cover. More on CorMedix
Moving together with CorMedix Stock
| 0.72 | DYAI | Dyadic International Financial Report 8th of May 2024 | PairCorr |
| 0.8 | ELYM | Eliem Therapeutics | PairCorr |
| 0.64 | ERNA | Eterna Therapeutics | PairCorr |
Moving against CorMedix Stock
| 0.82 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.77 | DNA | Ginkgo Bioworks Holdings Financial Report 8th of May 2024 | PairCorr |
| 0.51 | EGRX | Eagle Pharmaceuticals | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 20th of May 2024
CorMedix Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. CorMedix's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding CorMedix or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Director | Randy Milby | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering CorMedix report their recommendations after researching CorMedix's financial statements, talking to executives and customers, or listening in on CorMedix's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering CorMedix. The CorMedix consensus assessment is calculated by taking the average forecast from all of the analysts covering CorMedix. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from CorMedix's financial statements, CorMedix may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of CorMedix is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
CorMedix's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to CorMedix's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CorMedix's financial leverage. It provides some insight into what part of CorMedix's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
CorMedix (CRMD) is traded on NASDAQ Exchange in USA. It is located in 300 Connell Drive, Berkeley Heights, NJ, United States, 07922 and employs 82 people. CorMedix is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 290.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CorMedix's market, we take the total number of its shares issued and multiply it by CorMedix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CorMedix conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 54.98 M outstanding shares of which 8.25 M shares are currently shorted by private and institutional investors with about 15.92 trading days to cover.
CorMedix currently holds about 64.62 M in cash with (38.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.57.
Check CorMedix Probability Of Bankruptcy
Ownership AllocationCorMedix holds a total of 54.98 Million outstanding shares. 30% of CorMedix outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CorMedix Ownership Details
CorMedix Stock Price Odds Analysis
What are CorMedix's target price odds to finish over the current price? Based on a normal probability distribution, the odds of CorMedix jumping above the current price in 90 days from now is roughly 2.02%. The CorMedix probability density function shows the probability of CorMedix stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days CorMedix has a beta of -2.2423 suggesting as returns on its benchmark rise, returns on holding CorMedix are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, CorMedix is expected to outperform its benchmark. Additionally, corMedix has an alpha of 0.9665, implying that it can generate a 0.97 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of CorMedix to move above the current price in 90 days from now is roughly 2.02 (This CorMedix probability density function shows the probability of CorMedix Stock to fall within a particular range of prices over 90 days) .
CorMedix Stock Institutional Holders
Institutional Holdings refers to the ownership stake in CorMedix that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of CorMedix's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing CorMedix's value.| Instituion | Recorded On | Shares | |
| Nuveen Asset Management, Llc | 2023-12-31 | 241.5 K | |
| Renaissance Technologies Corp | 2023-12-31 | 235.7 K | |
| Barclays Plc | 2023-12-31 | 218.6 K | |
| Anson Funds Management Lp | 2023-12-31 | 199 K | |
| D. E. Shaw & Co Lp | 2023-09-30 | 186.2 K | |
| Susquehanna International Group, Llp | 2023-12-31 | 185.5 K | |
| Two Sigma Investments Llc | 2023-12-31 | 177.7 K | |
| Spinnaker Capital Llc | 2023-12-31 | 175.4 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 163.9 K | |
| Blackrock Inc | 2023-12-31 | 3.5 M | |
| Nomura Holdings Inc | 2023-12-31 | 2.9 M |
CorMedix Historical Income Statement
CorMedix Income Statement is one of the three primary financial statements used for reporting CorMedix's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of CorMedix revenue and expense. CorMedix Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, CorMedix's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Total Operating Expenses is expected to grow to about 51.4 M, whereas Research Development is forecasted to decline to about 10.2 M. View More FundamentalsCorMedix Stock Against Markets
Picking the right benchmark for CorMedix stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in CorMedix stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for CorMedix is critical whether you are bullish or bearish towards CorMedix at a given time. Please also check how CorMedix's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in CorMedix without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
CorMedix Corporate Directors
CorMedix corporate directors refer to members of a CorMedix board of directors. The board of directors generally takes responsibility for the CorMedix's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of CorMedix's board members must vote for the resolution. The CorMedix board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Mehmood Khan | Director | Profile | |
| Gary Gelbfish | Director | Profile | |
| Khoso Baluch | Director | Profile | |
| Taunia Markvicka | Independent Director | Profile |
How to buy CorMedix Stock?
Before investing in CorMedix, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in CorMedix. To buy CorMedix stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of CorMedix. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase CorMedix stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located CorMedix stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased CorMedix stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as CorMedix, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy CorMedix Stock please use our How to Invest in CorMedix guide.
Already Invested in CorMedix?
The danger of trading CorMedix is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of CorMedix is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than CorMedix. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile CorMedix is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether CorMedix is a strong investment it is important to analyze CorMedix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CorMedix's future performance. For an informed investment choice regarding CorMedix Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CorMedix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for CorMedix Stock analysis
When running CorMedix's price analysis, check to measure CorMedix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CorMedix is operating at the current time. Most of CorMedix's value examination focuses on studying past and present price action to predict the probability of CorMedix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CorMedix's price. Additionally, you may evaluate how the addition of CorMedix to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is CorMedix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CorMedix. If investors know CorMedix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CorMedix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.91) | Revenue Per Share 0.001 | Quarterly Revenue Growth (0.47) | Return On Assets (0.42) | Return On Equity (0.74) |
The market value of CorMedix is measured differently than its book value, which is the value of CorMedix that is recorded on the company's balance sheet. Investors also form their own opinion of CorMedix's value that differs from its market value or its book value, called intrinsic value, which is CorMedix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CorMedix's market value can be influenced by many factors that don't directly affect CorMedix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CorMedix's value and its price as these two are different measures arrived at by different means. Investors typically determine if CorMedix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CorMedix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.